Company Filing History:
Years Active: 2021-2023
Title: Samala Rajamouli Srihari: Innovator in Pharmaceutical Chemistry
Introduction
Samala Rajamouli Srihari is a notable inventor based in Thane, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of short-acting benzodiazepines. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Samala Rajamouli Srihari holds 2 patents. His latest patents include a process for the preparation of Remimazolam and solid-state forms of Remimazolam salts. The present disclosure relates to novel processes for the preparation of short-acting benzodiazepines, as well as to novel intermediates in this process. More particularly, the disclosure pertains to processes and intermediates for the preparation of Methyl 3-[(4S)-8-bromo-1-methyl-6-(pyridin-2-yl)-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate, commonly known as Remimazolam. The present disclosure also relates to solid-state forms of Remimazolam salts, processes for their preparation, pharmaceutical formulations/compositions thereof, and methods of use thereof.
Career Highlights
Throughout his career, Samala Rajamouli Srihari has worked with reputable companies in the pharmaceutical industry. Notable among these are Assia Chemical Industries Ltd. and Watson Laboratories Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Samala has collaborated with several professionals in his field, including Dolitzky Ben-Zion and Mendelovici Marioara. These collaborations have further enriched his research and development efforts.
Conclusion
Samala Rajamouli Srihari is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the preparation of benzodiazepines. His contributions are vital to the ongoing development of effective medical treatments.